14.05
-0.25 (-1.75%)
Penutupan Terdahulu | 14.30 |
Buka | 14.42 |
Jumlah Dagangan | 1,542,222 |
Purata Dagangan (3B) | 1,813,495 |
Modal Pasaran | 638,538,816 |
Harga / Pendapatan (P/E Ke hadapan) | 66.67 |
Harga / Jualan (P/S) | 2.07 |
Julat 52 Minggu | |
Tarikh Pendapatan | 5 Aug 2025 - 11 Aug 2025 |
Margin Keuntungan | -4.59% |
Margin Operasi (TTM) | 3.87% |
EPS Cair (TTM) | -0.330 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 48.80% |
Nisbah Semasa (MRQ) | 0.820 |
Aliran Tunai Operasi (OCF TTM) | 15.38 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 6.75 M |
Pulangan Atas Aset (ROA TTM) | -6.88% |
Pulangan Atas Ekuiti (ROE TTM) | -2,243.07% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Health Information Services (US) | Menaik | Bercampur |
Health Information Services (Global) | Menaik | Bercampur | |
Stok | LifeMD, Inc. | Menaik | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | -1.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -3.0 |
Purata Bergerak Teknikal | 1.5 |
Osilator Teknikal | -0.5 |
Purata | -0.88 |
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment. |
|
Sektor | Healthcare |
Industri | Health Information Services |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 15.99% |
% Dimiliki oleh Institusi | 37.56% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 18.00 (Lake Street, 28.11%) | Beli |
Median | 14.00 (-0.36%) | |
Rendah | 14.00 (Keybanc, -0.36%) | Beli |
14.00 (HC Wainwright & Co., -0.36%) | Beli | |
Purata | 15.33 (9.11%) | |
Jumlah | 3 Beli | |
Harga Purata @ Panggilan | 10.21 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Keybanc | 14 Jul 2025 | 14.00 (-0.36%) | Beli | 11.32 |
Lake Street | 10 Jul 2025 | 18.00 (28.11%) | Beli | 11.96 |
HC Wainwright & Co. | 30 Apr 2025 | 14.00 (-0.36%) | Beli | 7.36 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
23 Jun 2025 | Pengumuman | LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock |
09 Jun 2025 | Pengumuman | LifeMD to Participate in Two Investor Conferences During June |
22 May 2025 | Pengumuman | LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy® |
12 May 2025 | Pengumuman | LifeMD to Participate in Three Investor Conferences During May |
06 May 2025 | Pengumuman | LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance |
29 Apr 2025 | Pengumuman | LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients |
28 Apr 2025 | Pengumuman | LifeMD Acquires Women’s Health Provider Optimal Human Health MD to Accelerate Entry into the Women’s Health Market |
28 Apr 2025 | Pengumuman | LifeMD to Report First Quarter 2025 Financial Results on May 6 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |